China: Corporate/Commercial Law

China's foreign investment security review office has issued its first-ever prohibition of an AI sector acquisition, blocking Meta's purchase of Manus and requiring transaction reversal. This landmark case establishes new compliance boundaries for cross-border capital operations involving strategic AI technologies, demonstrating that offshore restructuring cannot circumvent substantive regulatory oversight of technology transfers.

根据国家药监局经国家医保局官网转引的数据，2026年截至6月30日，我国创新药对外授权共81笔，交易总额约1,100亿美元，已达到2025年全年总额的80%；交易覆盖肿瘤、代谢、免疫、神经等十个治疗领域，主要被许可方来自20个国家和地区。[1]前述“交易总额”是各笔交易披露的最高潜在可量化金额之和，通

The European Commission has released its first enforcement review of the Foreign Subsidies Regulation (FSR), declaring the framework 'fit for purpose' while proposing only targeted procedural adjustments.

2026年7月17日，以“智能伙伴 共创未来”为主题的2026世界人工智能大会暨人工智能全球治理高级别会议在上海启幕。这场盛会既展示着AI技术的迅猛发展，也引发了关于治理规则的深层思考——当AI“犯错”，谁来担责？

China has released its first comprehensive draft law targeting cross-border corruption, establishing new processes for international cooperation in investigations and imposing compliance obligations on companies engaged in cross-border business. The Draft Anti-Cross-Border Corruption Law introduces a coordinated enforcement model led by the National Supervisory Commission and incorporates counter-sanctions provisions, raising critical questions about how foreign companies and their Chinese subsidiaries will

China's trademark opposition procedure offers a strategic opportunity to challenge potentially conflicting trademark registrations during the three-month publication period, before they are formally approved. This procedural mechanism enables prior rights holders and interested parties to resolve disputes at the registration stage, significantly reducing the time and costs associated with post-registration invalidation proceedings or infringement litigation.

A Paris roundtable examined China's transformation into a biotechnology powerhouse and the strategic opportunities this creates for European life sciences companies and investors. Industry leaders discussed how to structure cross-border partnerships that leverage Chinese innovation and development speed while navigating intellectual property protection, regulatory frameworks, and evolving geopolitical considerations.

继中国证券监督管理委员会于2026年2月27日发布《私募投资基金信息披露监督管理办法》（以下简称《监督办法》）后，2026年3月13日，中国证券投资基金&#

岁月不居，时节如流。当2025年的日历翻至最后一页，我们再次站在年岁交替的交叉口，回望过往一年中国私募基金行业[1]的发展，又是充满机遇与挑&

股东知情权是股东了解公司、监督经营，进而行使表决权、分红权、提案权等一系列权利的“起点权利”。

根据我国现行《公司法》第二百六十五条规定，高级管理人员是指公司的经理、副经理、财务负责人，上市公司董事会秘书和公司章程规定的其他人员。前述高级管理人员，根据《公司法》或依据公司章程规定，通常需要由公司董事会决定聘任或解聘。大部分经由董事会聘任的高级管理人员A

2026年7月17日，以“智能伙伴 共创未来”为主题的2026世界人工智能大会暨人工智能全球治理高级别会议在上海启幕。这场盛会既展示着AI技术的迅猛发展，也引发了关于治理规则的深层思考——当AI“犯错”，谁来担责？